US Patent Issued to Aggamin on April 14 for "Methods and systems for treating pregnancy-related hypertensive disorders comprising anti-sEng and anti-sFlt-1 antibodies" (Maryland, New York Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,323, issued on April 14, was assigned to Aggamin LLC (New York).

"Methods and systems for treating pregnancy-related hypertensive disorders comprising anti-sEng and anti-sFlt-1 antibodies" was invented by Woo S. Joo (Gaithersburg, Md.), Karen M. Lee (Massapequa, N.Y.), Adelene Y. Tan (New York), Garrett D. Daniels (Mamaroneck, N.Y.) and Paul Kussie (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods and apparatuses for treating a pregnancy related hypertensive disorder, such as pre-eclampsia and eclampsia, using ex vivo treatment with an anti-sFlt-1 antibody and an anti-sEng antibody bound to a solid support in order to r...